These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6604916)

  • 1. Enhancement of specific antitumor immunity in mice fed a diet enriched in vitamin A acetate.
    Malkovský M; Doré C; Hunt R; Palmer L; Chandler P; Medawar PB
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6322-6. PubMed ID: 6604916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumor rejection by autologous anti-idiotypic immunity.
    Flood PM; Kripke ML; Rowley DA; Schreiber H
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2209-13. PubMed ID: 6966405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids.
    Dillehay DL; Shealy YF; Lamon EW
    Cancer Res; 1989 Jan; 49(1):44-50. PubMed ID: 2783245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy.
    Shu SY; Chou T; Rosenberg SA
    J Immunol; 1987 Jul; 139(1):295-304. PubMed ID: 2953816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo generation, enhancement and recruitment of host cellular immune responses against tumor: influence of MHC antigen expression on clones of tumor cell variants.
    Fernández-Cruz E; Pérez M; Zabay JM; Garrido F
    Prog Clin Biol Res; 1987; 244():115-25. PubMed ID: 2958867
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma.
    Chou T; Shu S
    J Immunol; 1987 Sep; 139(6):2103-9. PubMed ID: 2957448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cells.
    Shu S; Rosenberg SA
    J Immunol; 1985 Oct; 135(4):2895-903. PubMed ID: 2411817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
    Mulé JJ; Yang J; Shu S; Rosenberg SA
    J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
    Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
    Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
    Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
    Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of circulating T-lymphocytes mediating resistance to in vivo growth of a carcinogen-induced syngeneic rat tumor.
    Crum ED
    Cancer Res; 1984 Aug; 44(8):3196-201. PubMed ID: 6234986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of synergy between cyclophosphamide therapy and immunity against a mouse tumour.
    Chassoux DM; Gotch FM; MacLennan IC
    Br J Cancer; 1978 Aug; 38(2):211-8. PubMed ID: 698035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxic responses of spleen cells from mice bearing primary, chemically induced tumors.
    Civin CI; Dorfman N; Eggers A; Fink K; Penvose D; Hsu CK; Wunderlich JR
    J Immunol; 1979 Dec; 123(6):2550-7. PubMed ID: 159318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes.
    Lynch DH; Namen AE; Miller RE
    Eur J Immunol; 1991 Dec; 21(12):2977-85. PubMed ID: 1684156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic and in situ natural killer activity in C57BL/6N and CBA/N mice bearing murine sarcoma virus-induced regressor tumors.
    Gerson JM; Holden HT; Herberman RB
    J Natl Cancer Inst; 1980 Nov; 65(5):905-7. PubMed ID: 6253708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin E protection against tumor formation by transplanted murine sarcoma cells.
    Kurek MP; Corwin LM
    Nutr Cancer; 1982; 4(2):128-39. PubMed ID: 6761653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin-induced suppression of antitumor immunity.
    Roszkowski W; Lipinska R; Roszkowski K; Jeljaszewicz J; Pulverer G
    Med Microbiol Immunol; 1984; 172(4):197-205. PubMed ID: 6717373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.